Polymeric nanoparticle-encapsulated curcumin ("nanocurcumin"): A novel strategy for human cancer therapy

Journal of Nanobiotechnology

Volumn 5, Issue , 2007, Pages

  Bisht, Savita ^a   Feldmann, Georg ^a   Soni, Sheetal ^b   Ravi, Rajani ^a   Karikar, Collins ^a   Maitra, Amarnath ^b   Maitra, Anirban ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF DELHI   (India)

Author keywords

[No Author keywords available]

Indexed keywords

CELL VIABILITY; CLONOGENICITY ASSAYS; IN VIVO MODELS; NANOCURCUMIN; SOFT AGAR;

BIOASSAY; BIOPOLYMERS; CELLS; DRUG DELIVERY; ENCAPSULATION; NANOPARTICLES; POLYETHYLENE GLYCOLS; SOLUBILITY; VINYL RESINS;

ONCOLOGY;

1 VINYL 2 PYRROLIDINONE; ANTINEOPLASTIC AGENT; COPOLYMER; CURCUMIN; I KAPPA B KINASE; INTERLEUKIN 6; INTERLEUKIN 8; MACROGOL; NANOCURCUMIN; NANOPARTICLE; POLY(N ISOPROPYLACRYLAMIDE); POLYMER; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; AQUEOUS SOLUTION; ARTICLE; CANCER CELL; CELL ASSAY; CELL VIABILITY; CLONOGENESIS; CONTROLLED STUDY; CROSS LINKING; DOWN REGULATION; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG MECHANISM; DRUG SOLUBILITY; DRUG SYNTHESIS; ENCAPSULATION; ENZYME ACTIVATION; ENZYME INHIBITION; HUMAN; HUMAN CELL; LIGHT SCATTERING; MICELLIZATION; MOUSE; NANOPHARMACEUTICS; NONHUMAN; PANCREAS CANCER; PARTICLE SIZE; PHYSICAL CHEMISTRY; STEADY STATE; TRANSMISSION ELECTRON MICROSCOPY;

ANIMALIA; CURCUMA LONGA;

EID: 34248205135     PISSN: None     EISSN: 14773155     Source Type: Journal    
DOI: 10.1186/1477-3155-5-3     Document Type: Article

References (56)

1. Shishodia S Sethi G Aggarwal BB Curcumin: Getting back to the roots Ann N Y Acad Sci 2005 1056 206-217 10.1196/annals.1352.010 16387689
2. Mohandas KM Desai DC Epidemiology of digestive tract cancers in India. V. Large and small bowel Indian J Gastroenterol 1999 18 118-121 10407566
3. Sinha R Anderson DE McDonald SS Greenwald P Cancer risk and diet in India J Postgrad Med 2003 49 222-228 14597785
4. Maheshwari RK Singh AK Gaddipati J Srimal RC Multiple biological activities of curcumin: A short review Life Sci 2006 78 2081-2087 10.1016/j.lfs.2005.12.007 16413584
5. Duvoix A Blasius R Delhalle S Schnekenburger M Morceau F Henry E Dicato M Diederich M Chemopreventive and therapeutic effects of curcumin Cancer Lett 2005 223 181-190 10.1016/j.canlet.2004.09.041 15896452
6. Aggarwal BB Kumar A Bharti AC Anticancer potential of curcumin: preclinical and clinical studies Anticancer Res 2003 23 363-398 12680238
7. Wang Z Zhang Y Banerjee S Li Y Sarkar FH Notch-1 down-regulation by curcumin is associated with the inhibition of cell growth and the induction of apoptosis in pancreatic cancer cells Cancer 2006 106 2503-2513 10.1002/cncr.21904 16628653
8. Lev-Ari S Zinger H Kazanov D Yona D Ben-Yosef R Starr A Figer A Arber N Curcumin synergistically potentiates the growth inhibitory and pro-apoptotic effects of celecoxib in pancreatic adenocarcinoma cells Biomed Pharmacother 2005 59 Suppl 2 S276-280 10.1016/ S0753-3322(05)80045-9 16507392
9. Aggarwal BB Shishodia S Takada Y Banerjee S Newman RA Bueso-Ramos CE Price JE Curcumin suppresses the paclitaxel-induced nuclear factor-kappaB pathway in breast cancer cells and inhibits lung metastasis of human breast cancer in nude mice Clin Cancer Res 2005 11 7490-7498 10.1158/1078-0432.CCR-05-1192 16243823
10. Khor TO Keum YS Lin W Kim JH Hu R Shen G Xu C Gopalakrishnan A Reddy B Zheng X Combined inhibitory effects of curcumin and phenethyl isothiocyanate on the growth of human PC-3 prostate xenografts in immunodeficient mice Cancer Res 2006 66 613-621 10.1158/ 0008-5472.CAN-05-2708 16423986
11. Deeb D Jiang H Gao X Hafner MS Wong H Divine G Chapman RA Dulchavsky SA Gautam SC Curcumin sensitizes prostate cancer cells to tumor necrosis factor-related apoptosis-inducing ligand/Apo2L by inhibiting nuclear factor-kappaB through suppression of IkappaBalpha phosphorylation Mol Cancer Ther 2004 3 803-812 15252141
12. Lev-Ari S Strier L Kazanov D Madar-Shapiro L Dvory-Sobol H Pinchuk I Marian B Lichtenberg D Arber N Celecoxib and curcumin synergistically inhibit the growth of colorectal cancer cells Clin Cancer Res 2005 11 6738-6744 10.1158/1078-0432.CCR-05-0171 16166455
13. Inano H Onoda M Inafuku N Kubota M Kamada Y Osawa T Kobayashi H Wakabayashi K Chemoprevention by curcumin during the promotion stage of tumorigenesis of mammary gland in rats irradiated with gamma-rays Carcinogenesis 1999 20 1011-1018 10.1093/carcin/20.6.1011 10357781
14. Chuang SE Kuo ML Hsu CH Chen CR Lin JK Lai GM Hsieh CY Cheng AL Curcumin-containing diet inhibits diethylnitrosamine-induced murine hepatocarcinogenesis Carcinogenesis 2000 21 331-335 10.1093/carcin/ 21.2.331 10657978
15. Singh SV Hu X Srivastava SK Singh M Xia H Orchard JL Zaren HA Mechanism of inhibition of benzo[a]pyrene-induced forestomach cancer in mice by dietary curcumin Carcinogenesis 1998 19 1357-1360 10.1093/carcin/ 19.8.1357 9744529
16. Li N Chen X Liao J Yang G Wang S Josephson Y Han C Chen J Huang MT Yang CS Inhibition of 7,12-dimethylbenz[a]anthracene (DMBA)-induced oral carcinogenesis in hamsters by tea and curcumin Carcinogenesis 2002 23 1307-1313 10.1093/carcin/23.8.1307 12151348
17. Kawamori T Lubet R Steele VE Kelloff GJ Kaskey RB Rao CV Reddy BS Chemopreventive effect of curcumin, a naturally occurring anti-inflammatory agent, during the promotion/progression stages of colon cancer Cancer Res 1999 59 597-601 9973206
18. Cruz-Correa M Shoskes DA Sanchez P Zhao R Hylind LM Wexner SD Giardiello FM Combination treatment with curcumin and quercetin of adenomas in familial adenomatous polyposis Clin Gastroenterol Hepatol 2006 4 1035-1038 10.1016/j.cgh.2006.03.020 16757216
19. Sharma RA McLelland HR Hill KA Ireson CR Euden SA Manson MM Pirmohamed M Marnett LJ Gescher AJ Steward WP Pharmacodynamic and pharmacokinetic study of oral Curcuma extract in patients with colorectal cancer Clin Cancer Res 2001 7 1894-1900 11448902
20. Sharma RA Euden SA Platton SL Cooke DN Shafayat A Hewitt HR Marczylo TH Morgan B Hemingway D Plummer SM Phase I clinical trial of oral curcumin: biomarkers of systemic activity and compliance Clin Cancer Res 2004 10 6847-6854 10.1158/1078-0432.CCR-04-0744 15501961
21. Garcea G Jones DJ Singh R Dennison AR Farmer PB Sharma RA Steward WP Gescher AJ Berry DP Detection of curcumin and its metabolites in hepatic tissue and portal blood of patients following oral administration Br J Cancer 2004 90 1011-1015 10.1038/sj.bjc.6601623 14997198
22. Cheng AL Hsu CH Lin JK Hsu MM Ho YF Shen TS Ko JY Lin JT Lin BR Ming-Shiang W Phase I clinical trial of curcumin, a chemopreventive agent, in patients with high-risk or pre-malignant lesions Anticancer Res 2001 21 2895-2900 11712783
23. Lao CD Ruffin MTt Normolle D Heath DD Murray SI Bailey JM Boggs ME Crowell J Rock CL Brenner DE Dose escalation of a curcuminoid formulation BMC Complement Altern Med 2006 6 10 1434783 16545122 10.1186/ 1472-6882-6-10
24. Soni S Babbar AK Sharma RK Maitra A Delivery of hydrophobised 5-fluorouracil derivative to brain tissue through intravenous route using surface modified nanogels J Drug Target 2006 14 87-95 10.1080/ 10611860600635608 16608735
25. Tyagi R Lala S Verma AK Nandy AK Mahato SB Maitra A Basu MK Targeted delivery of arjunglucoside I using surface hydrophilic and hydrophobic nanocarriers to combat experimental leishmaniasis J Drug Target 2005 13 161-171 16036304
26. Li L Aggarwal BB Shishodia S Abbruzzese J Kurzrock R Nuclear factor-kappaB and IkappaB kinase are constitutively active in human pancreatic cells, and their down-regulation by curcumin (diferuloylmethane) is associated with the suppression of proliferation and the induction of apoptosis Cancer 2004 101 2351-2362 10.1002/ cncr.20605 15476283
27. Aggarwal BB Shishodia S Suppression of the nuclear factor-kappaB activation pathway by spice-derived phytochemicals: Reasoning for seasoning Ann N Y Acad Sci 2004 1030 434-441 10.1196/annals.1329.054 15659827
28. Aggarwal S Ichikawa H Takada Y Sandur SK Shishodia S Aggarwal BB Curcumin (diferuloylmethane) down-regulates expression of cell proliferation and antiapoptotic and metastatic gene products through suppression of IkappaBalpha kinase and Akt activation Mol Pharmacol 2006 69 195-206 16219905
29. Hidaka H Ishiko T Furuhashi T Kamohara H Suzuki S Miyazaki M Ikeda O Mita S Setoguchi T Ogawa M Curcumin inhibits interleukin 8 production and enhances interleukin 8 receptor expression on the cell surface:iMpact on human pancreatic carcinoma cell growth by autocrine regulation Cancer 2002 95 1206-1214 10.1002/cncr.10812 12216086
30. Shishodia S Amin HM Lai R Aggarwal BB Curcumin (diferuloylmethane) inhibits constitutive NF-kappaB activation, induces G1/S arrest, suppresses proliferation, and induces apoptosis in mantle cell lymphoma Biochem Pharmacol 2005 70 700-713 10.1016/j.bcp.2005.04.043 16023083
31. Bharti AC Donato N Aggarwal BB Curcumin (diferuloylmethane) inhibits constitutive and IL-6-inducible STAT3 phosphorylation in human multiple myeloma cells J Immunol 2003 171 3863-3871 14500688
32. Ferrara N Vascular endothelial growth factor and the regulation of angiogenesis Recent Prog Horm Res 2000 55 15-35 discussion 35-16. 11036931
33. van Vlerken LE Amiji MM Multi-functional polymeric nanoparticles for tumour-targeted drug delivery Expert Opin Drug Deliv 2006 3 205-216 10.1517/17425247.3.2.205 16506948
34. Torchilin VP Micellar nanocarriers: Pharmaceutical perspectives Pharm Res 2007 24 1-16 10.1007/s11095-006-9132-0 17109211
35. Gaucher G Dufresne MH Sant VP Kang N Maysinger D Leroux JC Block copolymer micelles: Preparation, characterization and application in drug delivery J Control Release 2005 109 169-188 10.1016/ j.jconrel.2005.09.034 16289422
36. Torchilin VP Targeted polymeric micelles for delivery of poorly soluble drugs Cell Mol Life Sci 2004 61 2549-2559 10.1007/s00018-004-4153-5 15526161
37. Kwon GS Polymeric micelles for delivery of poorly water-soluble compounds Crit Rev Ther Drug Carrier Syst 2003 20 357-403 10.1615/ CritRevTherDrugCarrierSyst.v20.i5.20 14959789
38. Panyam J Labhasetwar V Biodegradable nanoparticles for drug and gene delivery to cells and tissue Adv Drug Deliv Rev 2003 55 329-347 10.1016/ S0169-409X(02)00228-4 12628320
39. Gradishar WJ Albumin-bound paclitaxel: A next-generation taxane Expert Opin Pharmacother 2006 7 1041-1053 10.1517/14656566.7.8.1041 16722814
40. Singh S Khar A Biological effects of curcumin and its role in cancer chemoprevention and therapy Anticancer Agents Med Chem 2006 6 259-270 16712454
41. Aggarwal BB Shishodia S Molecular targets of dietary agents for prevention and therapy of cancer Biochem Pharmacol 2006 71 1397-1421 10.1016/j.bcp.2006.02.009 16563357
42. Choudhuri T Pal S Das T Sa G Curcumin selectively induces apoptosis in deregulated cyclin D1-expressed cells at G2 phase of cell cycle in a p53-dependent manner J Biol Chem 2005 280 20059-20068 10.1074/ jbc.M410670200 15738001
43. Tong QS Zheng LD Lu P Jiang FC Chen FM Zeng FQ Wang L Dong JH Apoptosis-inducing effects of curcumin derivatives in human bladder cancer cells Anticancer Drugs 2006 17 279-287 10.1097/ 00001813-200603000-00006 16520656
44. Ramachandran C You W Differential sensitivity of human mammary epithelial and breast carcinoma cell lines to curcumin Breast Cancer Res Treat 1999 54 269-278 10.1023/A:1006170224414 10445426
45. Syng-Ai C Kumari AL Khar A Effect of curcumin on normal and tumor cells: role of glutathione and bcl-2 Mol Cancer Ther 2004 3 1101-1108 15367704
46. Jiang MC Yang-Yen HF Yen JJ Lin JK Curcumin induces apoptosis in immortalized NIH 3T3 and malignant cancer cell lines Nutr Cancer 1996 26 111-120 8844727
47. Li L Braiteh FS Kurzrock R Liposome-encapsulated curcumin: In vitro and in vivo effects on proliferation, apoptosis, signaling, and angiogenesis Cancer 2005 104 1322-1331 10.1002/cncr.21300 16092118
48. Lim GP Chu T Yang F Beech W Frautschy SA Cole GM The curry spice curcumin reduces oxidative damage and amyloid pathology in an Alzheimer transgenic mouse J Neurosci 2001 21 8370-8377 11606625
49. Park SY Kim DS Discovery of natural products from Curcuma longa that protect cells from beta-amyloid insult: A drug discovery effort against Alzheimer's disease J Nat Prod 2002 65 1227-1231 10.1021/np010039x 12350137
50. Ono K Hasegawa K Naiki H Yamada M Curcumin has potent anti-amyloidogenic effects for Alzheimer's beta-amyloid fibrils in vitro J Neurosci Res 2004 75 742-750 10.1002/jnr.20025 14994335
51. Yang F Lim GP Begum AN Ubeda OJ Simmons MR Ambegaokar SS Chen PP Kayed R Glabe CG Frautschy SA Cole GM Curcumin inhibits formation of amyloid beta oligomers and fibrils, binds plaques, and reduces amyloid in vivo J Biol Chem 2005 280 5892-5901 10.1074/jbc.M404751200 15590663
52. Egan ME Pearson M Weiner SA Rajendran V Rubin D Glockner-Pagel J Canny S Du K Lukacs GL Caplan MJ Curcumin, a major constituent of turmeric, corrects cystic fibrosis defects Science 2004 304 600-602 10.1126/ science.1093941 15105504
53. Lipecka J Norez C Bensalem N Baudouin-Legros M Planelles G Becq F Edelman A Davezac N Rescue of DeltaF508-CFTR (cystic fibrosis transmembrane conductance regulator) by curcumin: Involvement of the keratin 18 network J Pharmacol Exp Ther 2006 317 500-505 10.1124/ jpet.105.097667 16424149
54. Davis PB Drumm ML Some like it hot: Curcumin and CFTR Trends Mol Med 2004 10 473-475 10.1016/j.molmed.2004.08.001 15464445
55. Feldmann G Beaty RM Hruban RH Maitra A Molecular genetics of pancreatic intraepithelial neoplasia J Hepatobiliary Pancreat Surg 2006
56. Karikari CA Mullendore M Eshleman JR Argani P Leoni LM Chattopadhyay S Hidalgo M Maitra A Homozygous deletions of methylthioadenosine phosphorylase in human biliary tract cancers Mol Cancer Ther 2005 4 1860-1866 10.1158/1535-7163.MCT-05-0103 16373701